3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
15
Rectal Neoplasms
14
Colonic Neoplasms
14
Stomach Neoplasms
10
Ovarian Neoplasms
7
Carcinoma, Hepatocellular
5
Gastrointestinal Stromal Tumors
4
Carcinoma, Renal Cell
4
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Liver Neoplasms
3
Neoplastic Cells, Circulating
2
Neoplasms
2
Kidney Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Incontinence
1
Surgical Wound Infection
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neuroendocrine Tumors
1
Ovarian Cysts
1
Obesity, Morbid
1
Neoplasm Metastasis
1
Interventions
Sorafenib
5
lenvatinib
2
ledipasvir, sofosbuvir drug combination
2
halofantrine
2
atezolizumab
2
Liver Transplantation
2
Immunotherapy
2
Control Groups
2
Blood Specimen Collection
2
Bevacizumab
2
Antibodies
2
veliparib
1
trifluridine tipiracil drug combination
1
trametinib
1
titanium silicide
1
sintilimab
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
linifanib
1
genexol-PM
1
fluorocholine
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
camrelizumab
1
belinostat
1
bavituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Diseases
×
Laparoscopy
×
Clear all
NCT01567631
2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA
Unknown
80 enrolled